100 related articles for article (PubMed ID: 35756689)
1. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma.
Yun D; Wang X; Wang W; Ren X; Li J; Wang X; Liang J; Liu J; Fan J; Ren X; Zhang H; Shang G; Sun J; Chen L; Li T; Zhang C; Yu S; Yang X
Front Oncol; 2022; 12():897702. PubMed ID: 35756689
[TBL] [Abstract][Full Text] [Related]
2. Identification of ferroptosis-related subtypes, characteristics of TME infiltration and development of prognostic models in gastric cancer.
Tang X; Yu Y; Liu N; Su Y; Zhang K; Zhai Z; Chen C; Sun W; Chen D; Ling R
Int Immunopharmacol; 2024 Mar; 130():111610. PubMed ID: 38402832
[TBL] [Abstract][Full Text] [Related]
3. A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer.
Zhou H; Zhou X; Zhu R; Zhao Z; Yang K; Shen Z; Sun H
Discov Oncol; 2024 May; 15(1):163. PubMed ID: 38743344
[TBL] [Abstract][Full Text] [Related]
4. Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes.
Zhu Y; He J; Wei R; Liu J
Immun Inflamm Dis; 2024 Apr; 12(4):e1221. PubMed ID: 38578040
[TBL] [Abstract][Full Text] [Related]
5. A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome.
Pham VVH; Jue TR; Bell JL; Luciani F; Michniewicz F; Cirillo G; Vahdat L; Mayoh C; Vittorio O
Hum Genet; 2024 Apr; ():. PubMed ID: 38642129
[TBL] [Abstract][Full Text] [Related]
6. PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma.
Wang X; Wang X; Li J; Liang J; Ren X; Yun D; Liu J; Fan J; Zhang Y; Zhang J; Ren X; Zhang H; Shang G; Sun J; Chen L; Chen L; Li T; Tong L; Zhang C; Yu S; Yang X
Cancer Gene Ther; 2023 Feb; 30(2):345-357. PubMed ID: 36434176
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor.
Zhu Q; Zhou Y; Wang H; Cao T; Wang X; Liu R; Wu H; Lin B
Med Oncol; 2023 Jul; 40(8):230. PubMed ID: 37421513
[TBL] [Abstract][Full Text] [Related]
8. Diffusion tensor imaging versus intraoperative subcortical mapping for glioma resection: a systematic review and meta-analysis.
Li Y; Guo J; Zhang K; Wei H; Fan J; Yu S; Li T; Yang X
Neurosurg Rev; 2023 Jun; 46(1):154. PubMed ID: 37380888
[TBL] [Abstract][Full Text] [Related]
9. Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2.
Liu Y; Chou FJ; Lang F; Zhang M; Song H; Zhang W; Davis DL; Briceno NJ; Zhang Y; Cimino PJ; Zaghloul KA; Gilbert MR; Armstrong TS; Yang C
Clin Cancer Res; 2023 Apr; 29(7):1305-1316. PubMed ID: 36648507
[TBL] [Abstract][Full Text] [Related]
10. Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy.
Ren X; Li T; Zhang W; Yang X
Cells; 2022 Aug; 11(16):. PubMed ID: 36010632
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics uncover the key ferroptosis regulators contribute to cancer progression in head and neck squamous cell carcinoma.
Liu F; Tang L; Li Q; Chen L; Pan Y; Yin Z; He J; Tian J
Front Mol Biosci; 2022; 9():962742. PubMed ID: 36003082
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors.
He J; Liu D; Liu M; Tang R; Zhang D
Front Mol Biosci; 2022; 9():961410. PubMed ID: 35992269
[No Abstract] [Full Text] [Related]
13. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a novel score for predicting postoperative 30‑day mortality in tumor craniotomy patients: A cross‑sectional diagnostic study.
Liu Y; Hu H; Han Y; Li Z; Yang J; Zhang X; Chen L; Chen F; Li W; Huang G
Oncol Lett; 2024 May; 27(5):205. PubMed ID: 38516688
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y; Wu X; Zhu J; Lu R; Ouyang Y
BMC Cancer; 2023 Nov; 23(1):1120. PubMed ID: 37978473
[TBL] [Abstract][Full Text] [Related]
16. Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways.
Li H; Liu J; Qin X; Sun J; Liu Y; Jin F
Cell Mol Neurobiol; 2023 Nov; 43(8):3929-3942. PubMed ID: 37747595
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma.
Chi H; Li B; Wang Q; Gao Z; Feng B; Xue H; Li G
Front Oncol; 2023; 13():1065994. PubMed ID: 36937406
[TBL] [Abstract][Full Text] [Related]
18. A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma.
Dai J; Pan Y; Chen Y; Yao S
Front Genet; 2022; 13():1024508. PubMed ID: 36406134
[No Abstract] [Full Text] [Related]
19. A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer.
Wang X; Xu Y; Dai L; Yu Z; Wang M; Chan S; Sun R; Han Q; Chen J; Zuo X; Wang Z; Hu X; Yang Y; Zhao H; Hu K; Zhang H; Chen W
Front Immunol; 2022; 13():1043738. PubMed ID: 36389694
[TBL] [Abstract][Full Text] [Related]
20. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
